ArticlebioRxiv : the preprint server for biology2026
Acquired resistance to the PRMT5 inhibitor confers collateral sensitivity to MEK inhibition in MTAP-null non-small cell lung cancer.
Rongjie Fu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.